InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,893.60
(
0.00%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.14
(
-0.33%
)
Bitcoin
57,013.13
(
0.54%
)
Post# of 252525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

stockbettor

Send PM Follow Ignore
Followers 3
Posts 278
Boards Moderated 0
Alias Born 03/08/2008

stockbettor

Re: DewDiligence post# 123505

Monday, 07/18/2011 12:51:26 PM

Monday, July 18, 2011 12:51:26 PM

Post# of 252525
I doubt Neulasta is covered by the settlement. Amgen's 10K shows the Neulasta US patent as expiring in Oct 2015. The ratiopharm Neulasta biosimilar is not yet on the market, but I recall a recent report from Teva that the PIII trial for the biosimilar was a success.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up